The demand for precision cancer imaging in Japan is projected to grow from USD 309.1 million in 2025 to USD 504.7 million by 2035, at a CAGR of 5.0%. Magnetic Resonance Imaging will dominate with a 32.2% market share, while hospitals will lead the end user segment with a 58.4% share.